Timothy Powers
Plus aucun poste en cours
Profil
Timothy Powers served as the Chief Executive Officer & Director at TabacaleraYsidron, Inc. and as the Chief Executive Officer at Mount Tam Biotechnologies, Inc. He also worked as the Director-Medicinal Chemistry at Amgen, Inc. and Alantos Pharmaceuticals Holding, Inc. Dr. Powers was also the Director & Chief Scientific Officer at Mount TAM Biotechnologies, Inc. He holds a doctorate degree from The University of Chicago and an undergraduate degree from the University of California, Davis.
Anciens postes connus de Timothy Powers
| Sociétés | Poste | Fin |
|---|---|---|
Mount TAM Biotechnologies, Inc.
 Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Directeur Général | 08/02/2016 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/01/2007 |
Mount Tam Biotechnologies, Inc. /Old/
 Mount Tam Biotechnologies, Inc. /Old/ BiotechnologyHealth Technology Mount Tam Biotechnologies, Inc. develops medical compounds and treatment for autoimmune diseases. Its product TAM-01, focuses on the treatment of Systemic Lupus Erythematosus (SLE)-the most common form of lupus. The company was founded by Chester Aldridge, Mohammad Modarres and Stelios T. Tzannis on October 12, 2014 and is headquartered in Walnut Creek, CA. | Directeur Général | - |
TabacaleraYsidron, Inc.
 TabacaleraYsidron, Inc. TobaccoConsumer Non-Durables TabacaleraYsidron, Inc. manufactures and distributes cigars. The company conducts its business principally through one operating subsidiary, Epicurean Cigars, Inc. It was founded by Steven J. Ysidron on November 8, 2011 and is headquartered in Chapel Hill, NC. | Directeur Général | - |
Formation de Timothy Powers
| University of California, Davis | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
TabacaleraYsidron, Inc.
TabacaleraYsidron, Inc. TobaccoConsumer Non-Durables TabacaleraYsidron, Inc. manufactures and distributes cigars. The company conducts its business principally through one operating subsidiary, Epicurean Cigars, Inc. It was founded by Steven J. Ysidron on November 8, 2011 and is headquartered in Chapel Hill, NC. | Consumer Non-Durables |
Mount Tam Biotechnologies, Inc. /Old/
Mount Tam Biotechnologies, Inc. /Old/ BiotechnologyHealth Technology Mount Tam Biotechnologies, Inc. develops medical compounds and treatment for autoimmune diseases. Its product TAM-01, focuses on the treatment of Systemic Lupus Erythematosus (SLE)-the most common form of lupus. The company was founded by Chester Aldridge, Mohammad Modarres and Stelios T. Tzannis on October 12, 2014 and is headquartered in Walnut Creek, CA. | Health Technology |
Mount TAM Biotechnologies, Inc.
Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Health Technology |
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Health Technology |
